Timing of Oxytocin Administration and Its Effect on Postpartum Hemorrhage

Advisor(s)

Sarah Bassit

Jamie Hunsicker

Megan Lieb

Confirmation

1

Document Type

Poster

Location

ONU McIntosh Center; Activities Room

Start Date

11-4-2025 11:00 AM

End Date

11-4-2025 11:50 AM

Abstract

Research has shown that delaying uterotonics after birth can lead to an increase in postpartum hemorrhage occurrences. Postpartum hemorrhage consists of excessive blood loss after giving birth. Adherence to an oxytocin protocol may decrease the number of postpartum hemorrhage occurrences. This study is being conducted to determine if oxytocin administration immediately after delivery compared to no immediate oxytocin administration affects postpartum hemorrhage. Participants will be women giving birth at St. Rita’s Lima Hospital. The protocol consists of a continuous oxytocin infusion of 2 IU/h, which is administered within 10 minutes following delivery and will be discontinued after 24 hours. Medical charts will be reviewed by data collectors 3 months prior to the implementation of the protocol, and 3 months after the implementation to determine if the amount of postpartum hemorrhage occurrences decreases. Some of the factors being examined will be hemoglobin levels, hematocrit levels, and obvious uterine hemorrhage. This study will be beneficial for patients by possibly decreasing postpartum hemorrhage rates and maternal mortality.

This document is currently not available here.

Restricted

Available to ONU community via local IP address and ONU login.

Share

COinS
 
Apr 11th, 11:00 AM Apr 11th, 11:50 AM

Timing of Oxytocin Administration and Its Effect on Postpartum Hemorrhage

ONU McIntosh Center; Activities Room

Research has shown that delaying uterotonics after birth can lead to an increase in postpartum hemorrhage occurrences. Postpartum hemorrhage consists of excessive blood loss after giving birth. Adherence to an oxytocin protocol may decrease the number of postpartum hemorrhage occurrences. This study is being conducted to determine if oxytocin administration immediately after delivery compared to no immediate oxytocin administration affects postpartum hemorrhage. Participants will be women giving birth at St. Rita’s Lima Hospital. The protocol consists of a continuous oxytocin infusion of 2 IU/h, which is administered within 10 minutes following delivery and will be discontinued after 24 hours. Medical charts will be reviewed by data collectors 3 months prior to the implementation of the protocol, and 3 months after the implementation to determine if the amount of postpartum hemorrhage occurrences decreases. Some of the factors being examined will be hemoglobin levels, hematocrit levels, and obvious uterine hemorrhage. This study will be beneficial for patients by possibly decreasing postpartum hemorrhage rates and maternal mortality.